Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v3.23.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities:    
Net income $ 15,405 $ 19,208
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for loan losses 25,246 16,579
Depreciation and amortization 5,076 4,810
Share-based compensation expense 1,457 745
Net losses on disposal property and equipment 29 5
Increase in deferred income tax liability 3,613 5,273
Changes in operating assets and liabilities:    
Notes receivable (47,074) (23,874)
VOI Inventory 8,656 7,898
Prepaid expenses and other assets (7,172) (6,976)
Accounts payable, accrued liabilities and other, and deferred income (28,984) 5,824
Net cash (used in) provided by operating activities (23,748) 29,492
Investing activities:    
Purchases of property and equipment (3,924) (4,895)
Net cash used in investing activities (3,924) (4,895)
Financing activities:    
Repayments of notes payable and other borrowings (69,725) (33,970)
Proceeds from notes payable and other borrowings 84,901 58,397
Payments for debt issuance costs (118) (1,697)
Issuance of common stock from vesting restricted stock awards (8)  
Purchase and retirement of common stock   (4,702)
Dividends paid on common stock (3,408)  
Net cash provided by financing activities 11,642 18,028
Net (decrease) increase in cash, cash equivalents and restricted cash (16,030) 42,625
Cash, cash equivalents and restricted cash at beginning of period 226,528 183,079
Cash, cash equivalents and restricted cash at end of period 210,498 225,704
Supplemental cash flow information:    
Interest paid on borrowings, net of amounts capitalized 14,232 5,951
Income taxes paid 1,147 704
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 166,663 179,274
Restricted cash 43,835 46,430
Total cash, cash equivalents, and restricted cash $ 210,498 $ 225,704